Le Lézard
Classified in: Health, Business
Subject: LIC

San Francisco Health Plan Continues its Partnership with PerformRx® as its Pharmacy Benefit Manager


SAN FRANCISCO, Jan. 8, 2019 /PRNewswire/ -- San Francisco Health Plan (SFHP), a community managed care health plan serving over 140,000 San Francisco residents, announced today that it is continuing and expanding its partnership with PerformRx to manage its pharmacy benefits.

Since July 2013, SFHP and PerformRx have been working together to provide pharmacy services to our members that improve patient outcomes while focusing on fiscal responsibility and financial performance. The continued partnership will help ensure excellent pharmacy management and benefit services for our members.

"Five years ago we chose PerformRx as our pharmacy benefit manager, knowing that they were going to assist us in our core values -- ensuring excellent service, quality, and affordability for our members," said John F. Grgurina, Jr., CEO of San Francisco Health Plan. "Since that time, they have grown to share in our mission and in our dedication of delivering high quality health care. I'm looking forward to seeing our partnership develop as we strive toward our goal of universal coverage for the people of San Francisco."

Jim Glauber, MD, MPH, SFHP's Chief Medical Officer stated, "Getting medicines to our members when they are prescribed in a timely, accessible manner is an enormous task. PerformRx supported us by delivering an aggressive generic management, enhanced client reporting system, an improved Prior Authorization process, and more. These tools allow us to deliver the excellent pharmacy services our members have come to expect and deserve." 

Working with Excelsior Solutions pharmacy consultants, San Francisco Health Plan enlisted an iterative qualitative scoring and financial analysis process from request for proposal to final selection. 

PerformRx is a clinician-led pharmacy benefit manager providing prescription drug claim processing, pharmacy network management and clinical support for Medicare, Medi-Cal and commercial plans. 

About San Francisco Health Plan
San Francisco Health Plan, a licensed community health plan providing affordable health coverage to over 140,000 low and moderate-income families residing in San Francisco. Designed for and by the residents it serves?many of whom would not be able to obtain health care for themselves or their families, SFHP members have access to a full spectrum of medical services including preventive care, hospitalization, prescription drugs, family planning, and substance abuse programs. SFHP's mission is to improve health outcomes of the diverse San Francisco communities through its successful partnerships. SFHP's Medicaid (Medi-Cal) line of business has earned "Accredited" status from the National Committee for Quality Assurance (NCQA). SFHP is also the third party administrator for the nationally recognized Healthy San Francisco program. For more information on SFHP, visit www.sfhp.org,

 

SOURCE San Francisco Health Plan


These press releases may also interest you

at 03:11
The eighth Aurora Prize for Awakening Humanity was awarded Thursday evening to Dr. Denis Mukwege, a world-renown gynecological surgeon and human rights activist from the Democratic Republic of the Congo (DRC). Dr. Mukwege is the president of Panzi...

at 03:05
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK's National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to...

at 03:00
Charging an electric vehicle (EV) at home is certainly more convenient than using a public charging station, but what are the other benefits? Along with convenience, the...

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...



News published on and distributed by: